These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8204575)

  • 21. The solution structure of parsley [2Fe-2S]ferredoxin.
    Im SC; Liu G; Luchinat C; Sykes AG; Bertini I
    Eur J Biochem; 1998 Dec; 258(2):465-77. PubMed ID: 9874213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of functional domains in vertebrate-type ferredoxins.
    Kostic M; Pochapsky SS; Obenauer J; Mo H; Pagani GM; Pejchal R; Pochapsky TC
    Biochemistry; 2002 May; 41(19):5978-89. PubMed ID: 11993992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of backbone dynamics of oxidized and reduced putidaredoxin by 15N NMR relaxation measurements.
    Sari N; Holden MJ; Mayhew MP; Vilker VL; Coxon B
    Biochemistry; 1999 Aug; 38(31):9862-71. PubMed ID: 10433692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solution structure of an artificial Fe8S8 ferredoxin: the D13C variant of Bacillus schlegelii Fe7S8 ferredoxin.
    Aono S; Bentrop D; Bertini I; Cosenza G; Luchinat C
    Eur J Biochem; 1998 Dec; 258(2):502-14. PubMed ID: 9874217
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of C73G putidaredoxin from Pseudomonas putida.
    Smith N; Mayhew M; Holden MJ; Kelly H; Robinson H; Heroux A; Vilker VL; Gallagher DT
    Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):816-22. PubMed ID: 15103126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hot-spot residues in the cytochrome P450cam-putidaredoxin binding interface.
    Hiruma Y; Gupta A; Kloosterman A; Olijve C; Olmez B; Hass MA; Ubbink M
    Chembiochem; 2014 Jan; 15(1):80-6. PubMed ID: 24302683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The conformation of P450cam in complex with putidaredoxin is dependent on oxidation state.
    Myers WK; Lee YT; Britt RD; Goodin DB
    J Am Chem Soc; 2013 Aug; 135(32):11732-5. PubMed ID: 23901883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and classification of hyperfine-shifted 1H, 2H, and 15N resonances of the Rieske ferredoxin component of toluene 4-monooxygenase.
    Xia B; Pikus JD; Xia W; McClay K; Steffan RJ; Chae YK; Westler WM; Markley JL; Fox BG
    Biochemistry; 1999 Jan; 38(2):727-39. PubMed ID: 9888813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An NMR-derived model for the solution structure of oxidized Thermotoga maritima 1[Fe4-S4] ferredoxin.
    Sticht H; Wildegger G; Bentrop D; Darimont B; Sterner R; Rösch P
    Eur J Biochem; 1996 May; 237(3):726-35. PubMed ID: 8647119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for oxidation-state-dependent conformational changes in human ferredoxin from multinuclear, multidimensional NMR spectroscopy.
    Xia B; Volkman BF; Markley JL
    Biochemistry; 1998 Mar; 37(11):3965-73. PubMed ID: 9521718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structure of the cytochrome p450cam-putidaredoxin complex determined by paramagnetic NMR spectroscopy and crystallography.
    Hiruma Y; Hass MA; Kikui Y; Liu WM; Ölmez B; Skinner SP; Blok A; Kloosterman A; Koteishi H; Löhr F; Schwalbe H; Nojiri M; Ubbink M
    J Mol Biol; 2013 Nov; 425(22):4353-65. PubMed ID: 23856620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NMR studies of putidaredoxin: associations of putidaredoxin with NADH-putidaredoxin reductase and cytochrome p450cam.
    Aoki M; Ishimori K; Morishima I
    Biochim Biophys Acta; 1998 Jul; 1386(1):168-78. PubMed ID: 9675270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The solution structure of bovine ferricytochrome b5 determined using heteronuclear NMR methods.
    Muskett FW; Kelly GP; Whitford D
    J Mol Biol; 1996 Apr; 258(1):172-89. PubMed ID: 8613986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A solution NMR molecular model for the aspartate-ligated, cubane cluster containing ferredoxin from the hyperthermophilic archeaon Pyrococcus furiosus.
    Sham S; Calzolai L; Wang PL; Bren K; Haarklau H; Brereton PS; Adams MW; La Mar GN
    Biochemistry; 2002 Oct; 41(41):12498-508. PubMed ID: 12369841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new assignment strategy for the hyperfine-shifted 13C and 15N resonances in Fe2S2 ferredoxins.
    Jain NU; Pochapsky TC
    Biochem Biophys Res Commun; 1999 Apr; 258(1):54-9. PubMed ID: 10222234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A model for effector activity in a highly specific biological electron transfer complex: the cytochrome P450(cam)-putidaredoxin couple.
    Pochapsky SS; Pochapsky TC; Wei JW
    Biochemistry; 2003 May; 42(19):5649-56. PubMed ID: 12741821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solution structure of the oxidized Fe7S8 ferredoxin from the thermophilic bacterium Bacillus schlegelii by 1H NMR spectroscopy.
    Aono S; Bentrop D; Bertini I; Donaire A; Luchinat C; Niikura Y; Rosato A
    Biochemistry; 1998 Jul; 37(27):9812-26. PubMed ID: 9657695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Production and characterization of a functional putidaredoxin reductase-putidaredoxin covalent complex.
    Churbanova IY; Poulos TL; Sevrioukova IF
    Biochemistry; 2010 Jan; 49(1):58-67. PubMed ID: 19954240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solution structure of the toluene 4-monooxygenase effector protein (T4moD).
    Hemmi H; Studts JM; Chae YK; Song J; Markley JL; Fox BG
    Biochemistry; 2001 Mar; 40(12):3512-24. PubMed ID: 11297417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Probing the interactions of putidaredoxin with redox partners in camphor P450 5-monooxygenase by mutagenesis of surface residues.
    Holden M; Mayhew M; Bunk D; Roitberg A; Vilker V
    J Biol Chem; 1997 Aug; 272(35):21720-5. PubMed ID: 9268300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.